| 1. |
?Kitano S, Iso Y, Moriyama M, et al. Laparoscopy-assisted BillrothⅠgastrectomy. Surg Laparosc Endosc, 1994, 4(2): 146-148.
|
| 2. |
余佩武, 羅華星.腹腔鏡胃癌手術規范化實施的策略與技術.中華消化外科雜志, 2015, 14(3): 179-182.
|
| 3. |
王紅巖, 趙曉丹, 李國勝, 等.腹腔鏡輔助與開腹胃癌D2根治術治療局部進展期遠端胃癌的安全性及近期療效Meta分析.中國醫科大學學報, 2015, 44(3): 252-258.
|
| 4. |
李長風, 黃娜, 于濤.腹腔鏡直腸癌根治術后胃腸功能的恢復優勢及機制探討.醫學理論與實踐, 2015, 28(18): 2469-2470.
|
| 5. |
Coate KC, Kliewer SA, Mangelsdorf DJ. SnapShot: hormones of the gastrointestinal tract. Cell, 2014, 159(6): 1478-1478.e1.
|
| 6. |
中華醫學會外科分會腹腔鏡與內鏡外科學組.腹腔鏡胃惡性腫瘤手術操作指南(2007版).外科理論與實踐, 2007, 12(6): 610-614.
|
| 7. |
謝翠, 賴麗蓮.綜合干預措施對腎癌術后患者胃腸道功能恢復的影響.世界華人消化雜志, 2015, 14(23): 2328-2332.
|
| 8. |
曹暉, 卞育海, 趙剛.進一步認識和提高進展期胃癌綜合治療的理念.中華胃腸外科雜志, 2014, 17(11): 1051-1059.
|
| 9. |
Piessen G, Lefèvre JH, Cabau M, et al. Laparoscopic versus open surgery for gastric gastrointestinal stromal tumors: what is the impact on postoperative outcome and oncologic results? Ann Surg, 2015, 262(5): 831-840.
|
| 10. |
白洪祥, 劉現立.腹腔鏡下結腸癌根治術安全性及對患者術后胃腸道功能的影響.中國老年學雜志, 2014, 34(14): 4039-4040.
|
| 11. |
王錫山.腹部手術后不容忽視的問題—消化道功能障礙.中華胃腸外科雜志, 2015, 18(5): 509-511.
|
| 12. |
T?rnblom H, Simrén M, Abrahamsson H. Gastrointestinal motility and neurogastroenterology. Scand J Gastroenterol, 2015, 50(6): 685-697.
|
| 13. |
王歡, 黃永坤, 劉梅.胃腸激素與胃腸道功能及疾病的關系.醫學綜述, 2013, 19(15): 2735-2738.
|
| 14. |
Andreas S, Yvette T. Interaction between gastric and upper small intestinal hormones in the regulation of hunger and satiety: ghrelin and cholecystokinin take the central stage. Curr Protein Pept Sci, 2011, 12(4): 293-304.
|
| 15. |
Sanger GJ. Ghrelin and motilin receptor agonists: time to introduce bias into drug design. Neurogastroenterol Motil, 2014, 26(2): 149-155.
|
| 16. |
全俊, 嚴晉, 丁懿, 等. D-IBS與FD重疊征大鼠精神狀態、胃腸激素水平改變.胃腸病學和肝病學雜志, 2015, 24(8): 930-934.
|
| 17. |
Vu JP, Larauche M, Flores M, et al. Regulation of appetite, body composition, and metabolic hormones by vasoactive intestinal polypeptide (VIP). J Mol Neurosci, 2015, 56(2): 377-387.
|